Ethic Inc. Bio Rad Laboratories, Inc. Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ethic Inc. holds 3,665 shares of BIO stock, worth $831,698. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,665

Previous 1,598 129.35%

Holding current value

$831,698

Previous $524,000 70.23%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$243.0 - $367.0 $502,281 - $758,589	2,067 Added 129.35%	3,665 $892,000
Q4 2024 Feb 14, 2025	BUY	$313.15 - $374.28 $163,464 - $195,374	522 Added 48.51%	1,598 $524,000
Q3 2024 Nov 13, 2024	BUY	$263.97 - $344.64 $34,844 - $45,492	132 Added 13.98%	1,076 $360,000
Q2 2024 Aug 13, 2024	SELL	$268.26 - $339.48 $35,410 - $44,811	-132 Reduced 12.27%	944 $257,000
Q1 2024 May 13, 2024	SELL	$304.11 - $351.99 $113,128 - $130,940	-372 Reduced 25.69%	1,076 $372,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $108,556 - $147,111	403 Added 38.56%	1,448 $467,000
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $146,754 - $177,081	-419 Reduced 28.62%	1,045 $374,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $125,462 - $169,753	-349 Reduced 19.25%	1,464 $555,000
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $115,558 - $138,828	-276 Reduced 13.21%	1,813 $868,000
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $51,349 - $66,577	146 Added 7.51%	2,089 $878,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $316,043 - $431,457	766 Added 65.08%	1,943 $811,000
Q2 2022 Aug 10, 2022	BUY	$463.67 - $597.16 $545,739 - $702,857	1,177 New	1,177 $583,000

Others Institutions Holding BIO

# of Institutions

462

Shares Held

18.9M

Call Options Held

12.7K

Put Options Held

14.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $5.59B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account